Porton Pharma Solutions Ltd. continues to expand its reach globally. Last year, we launched the construction of a new site in Menges, Slovenia. The state-of-the-art GMP manufacturing site will significantly expand Porton’s network beyond China and the US as it sets out to provide solutions to customers and partners in Europe.

Moreover, Porton also started production in its Drug Product cdmo and cell and gene therapy CDMO commercialization facilities. It also began implementing the APS (Advanced Planning and Scheduling) to boost the efficiency in production scheduling and order fulfillment and promote transparency in capacity planning management.

All these production and operation efforts are part of Porton’s commitment to providing high-quality services.